Teledact Welcomes Two New Members To Its Advisory Board To Guide Company Through Future Growth

Published janvier 17, 2022

October 5, 2020 – Teledact Inc. (Gotodoctor.ca) is pleased to announce the addition of two new members to its Board of Advisors. Joining the Advisory Board are Rebecca Yu and Dr. Pierre Geoffroy, who will leverage their skills and expertise to provide guidance to the Company’s executive team through its continued growth in the virtual care sector.

“We are extremely happy to welcome such talented and experienced leaders to advise our team on future growth and opportunities,” said Tommy Cheung, President of Teledact. “Their combined expertise in public affairs, medicine, and the pharmaceutical industry will play a valuable role in both guiding our strategic decisions, and in broadening our services to provide better healthcare for all Canadians.”

“Although we have been using telemedicine for years, the COVID-19 pandemic has ignited virtual care adoption,” said Dr. Geoffroy. “I am excited to have the opportunity to help Teledact continue its impressive growth in bringing healthcare closer to our patients.”

About Rebecca Yu

Rebecca Yu is the Vice President, Market Access & External Affairs at Takeda Canada. Prior to assuming this role, she held the position of Head, JLABS Canada and was instrumental in setting up J&J Innovation’s first international JLABS incubator in partnership with the Ontario Government, University of Toronto, MaRS Innovation and 8 research hospitals, to help catalyze life science start-ups through the translation of science into valuable solutions for patients. Rebecca has over 20 years of pharmaceutical industry experience in a range of positions with Solvay Pharma, P&G, Servier, Pfizer and Janssen, covering value based access, external affairs, HTA, health policy, innovation sourcing, business development, alliance building, venture capital, and public-private partnerships.

Prior to joining industry, she practiced as a Clinical Pharmacist at The Wellesley Hospital. Rebecca is a graduate of the University of Toronto, Faculty of Pharmacy. Rebecca was previously on the Board of Directors for the Markham Stouffville Hospital, the Life Sciences Ontario Association, the Centre for the Commercialization of Regenerative Medicines (CCRM), the Nanomedicines Innovation Network (NMIN) and was a member of the Joint Steering Committee for the University of Toronto’s Neuroscience Catalyst. Rebecca was appointed to the Government of Canada’s Selection Committee for Venture Capital Catalyst Initiative (VCCI) to provide recommendations on selection of recipients of over $400M in VC funds. She is currently on the Ryerson University FEAS Dean’s Advisory Council, on the Canadian Pharmaceutical Sciences Foundation Board and a volunteer with the COVID-19 physician-led initiative on Critical Care Medicines.

About Dr. Pierre Geoffroy, MDCM, MSC, FCFP, DABAM

Dr. Geoffroy is currently an attending physician at Newmarket Health Centre and Lakeview Manor in Beaverton. He is also the house physician at a senior living centre and practices family medicine in Aurora. Previously, Pierre spent several years as an Assistant Professor of Medicine at McGill University before joining the Pharmaceutical Industry, where he held several senior positions in research and development at Wyeth Pharmaceuticals, Sanofi Pasteur, Biovail, and INC Research.

Early in his career, Dr. Geoffroy practiced emergency medicine in both Montreal and Newmarket, and has since then continued in family practice and geriatric medicine. Over the past 7 years, he has extended his work to include addiction patients at his local practice and at his addiction medicine clinic in Oshawa.

Dr. Geoffroy attended Medical School at McGill University and holds a BSc in Nutrition from McGill and a MSc in Human Nutrition from the University of Toronto. He is a Diplomate of the American Board of Addiction Medicine, being board-certified in Addiction Medicine. His area of interest lies in addiction disease and concomitant mental health disorders. Pierre is bilingual in French and English and holds medical Licenses in Quebec and Ontario.

 

About Teledact Inc.


Teledact (Gotodoctor.ca) is a leading telemedicine technology provider that focuses on improving healthcare access and medical resource distribution across Canada. Supported by the renowned primary care clinic, Enhanced Care Clinic, the Company offers complete virtual clinic solutions that conveniently connect patients with physicians. Enhanced Care has also been the Preferred Provider of Physician and Medical Clinic Services for McKesson Retail Banner Group (over 2,000 IDA, Guardian, Remedy’sRx and other independent pharmacies) since 2017. The Teledact platform now operates in a growing number of telemedicine clinics, pharmacies, health facilities and senior living centres across Canada. Gotodoctor.ca is also a listed virtual care provider on all McKesson Retail Banner Group consumer-facing portals.

Related News Stories

Nouvelles récentes

février 6, 2023

Gotodoctor.ca Expands Virtual Care Network

February 5, 2023 - Gotodoctor.ca, a leading Canadian provider of virtual healthcare and services is happy to announce...

En savoir plus
janvier 15, 2023

Gotodoctor.ca Enters an Agreement to Partner with Quick Health Access

January 15, 2023 – Gotodoctor.ca, a leading healthcare access solution company in Canada, is pleased to announce it...

En savoir plus
janvier 3, 2023

Gotodoctor.ca Has Been Accepted to Join The MaRS Community

January 3, 2023 – Gotodoctor.ca, a leading healthcare access solution company in Canada, is pleased to announce it...

En savoir plus

Rendez-vous

Veuillez sélectionner l’une des options suivantes

Santé Manitoba
Santé Ontario
Autres

Rendez-vous

Veuillez sélectionner l’une des options suivantes

Santé Manitoba
Santé Ontario
Autres